nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of the influence of the APOE gene on the incidence of type 2 diabetes mellitus in a cohort of workers: Effect of diet and shift work
|
Mateo-Gallego, Rocío |
|
|
|
5 |
p. 226-235 |
artikel |
2 |
A case of hypocholesterolemia under research
|
Camacho, Ana |
|
|
|
5 |
p. 244-247 |
artikel |
3 |
Accuracy of visceral adiposity indices and lipid accumulation products in the identification of adults at high cardiovascular risk
|
Milla, Ana Maria Gonçalvez |
|
|
|
5 |
p. 236-242 |
artikel |
4 |
Adhesion to the Mediterranean diet in diabetic patients with poor control
|
Celada Roldan, Carmen |
|
2019 |
|
5 |
p. 210-217 |
artikel |
5 |
Advanced oxidation protein products and their relationship with cardiovascular risk factors in young apparently healthy people
|
Villalpando Sánchez, Diana Carolina |
|
2017 |
|
5 |
p. 209-215 7 p. |
artikel |
6 |
Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway
|
Ye, Miaoqing |
|
|
|
5 |
p. 257-266 |
artikel |
7 |
Arteriosclerosis and other diseases in heads of government and its consequences for the population
|
Carmena, Rafael |
|
|
|
5 |
p. 267-271 |
artikel |
8 |
Association between non alcoholic fatty liver disease, metabolic and vascular risk
|
Elosua-Bayés, Iker |
|
|
|
5 |
p. 200-205 |
artikel |
9 |
Atherogenic indices: usefulness as predictors of cardiovascular disease
|
Tamarit García, Juan José |
|
|
|
5 |
p. 269-270 |
artikel |
10 |
Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis
|
Slouma, Maroua |
|
|
|
5 |
p. 261-268 |
artikel |
11 |
Cardiovascular risk factors and oxidative stress in young people
|
Rodrigues-Díez, Raquel |
|
2017 |
|
5 |
p. 216-217 2 p. |
artikel |
12 |
Cardiovascular risk, Metabolic disease and NASH control for Health Empowerment: Future endeavours
|
Martínez-Urbistondo, Diego |
|
|
|
5 |
p. 206-208 |
artikel |
13 |
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU)
|
Masana, Lluís |
|
|
|
5 |
p. 183-192 |
artikel |
14 |
Communication between levels of care: An opportunity for improvement in cardiovascular prevention
|
Gómez-Barrado, José Javier |
|
2019 |
|
5 |
p. 222-227 |
artikel |
15 |
Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®)
|
Pintó, Xavier |
|
|
|
5 |
p. 219-229 |
artikel |
16 |
Decalogue of the Spanish Society of Arteriosclerosis to reduce therapeutic inertia
|
Blasco, Mariano |
|
2017 |
|
5 |
p. 218-223 6 p. |
artikel |
17 |
Dr Esperanza María Martorell Mateu
|
Pocoví, Miguel |
|
2018 |
|
5 |
p. 248 |
artikel |
18 |
Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practice
|
Cosín-Sales, Juan |
|
|
|
5 |
p. 253-260 |
artikel |
19 |
Editorial: Arterial stiffness and cardiovascular disease. Prognostic value and applicability in clinical practice
|
Armario, Pedro |
|
|
|
5 |
p. 254-256 |
artikel |
20 |
Effect of an individualised physical exercise program on lipid profile in sedentary patients with cardiovascular risk factors
|
Rubio Pérez, Francisco Javier |
|
2017 |
|
5 |
p. 201-208 8 p. |
artikel |
21 |
Effect of clopidogrel vs. aspirin on pro-atherosclerotic NLRP1 inflammasome expression in endothelial cells. ECLOAS study
|
Bleda, Silvia |
|
|
|
5 |
p. 193-199 |
artikel |
22 |
Effect of resveratrol on seric vascular endothelial growth factor concentrations during atherosclerosis
|
Figueira, Leticia |
|
2018 |
|
5 |
p. 209-216 |
artikel |
23 |
Familial hypercholesterolemia: Experience in the Lipid Clinic of Alava
|
Pérez García, Leire |
|
2018 |
|
5 |
p. 224-229 |
artikel |
24 |
Familial hypercholesterolemia: Experience in the Lipid Clinic of Alava
|
Irigoyen Cucalón, Luis |
|
2019 |
|
5 |
p. 244 |
artikel |
25 |
Familial hypercholesterolemia in Gran Canaria: Founder mutation effect and high frequency of diabetes
|
Sánchez-Hernández, Rosa M. |
|
|
|
5 |
p. 247-253 |
artikel |
26 |
Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023
|
Pérez-Martínez, Pablo |
|
|
|
5 |
p. 248-261 |
artikel |
27 |
Hypercholesterolaemia control in Spain: The same situation with different regional realities
|
Pedro-Botet, Juan |
|
|
|
5 |
p. 219-225 |
artikel |
28 |
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors
|
Seijas-Amigo, Jose |
|
|
|
5 |
p. 245-252 |
artikel |
29 |
Influence of the confinement that occurred in Spain due to the SARS-CoV-2 virus outbreak on adherence to the Mediterranean diet
|
Carbayo Herencia, Julio A. |
|
|
|
5 |
p. 235-246 |
artikel |
30 |
Interplay between epicardial adipose tissue, metabolic and cardiovascular diseases
|
Bornachea, Olga |
|
2018 |
|
5 |
p. 230-239 |
artikel |
31 |
Is it necessary to perform cardiovascular screening in migrant patients?
|
Roa-Chamorro, Ricardo |
|
|
|
5 |
p. 285-290 |
artikel |
32 |
LDL as a therapeutic target
|
Díaz Rodríguez, Ángel |
|
|
|
5 |
p. 271-284 |
artikel |
33 |
Management of atherogenic dyslipidemia in the primary care setting in Spain
|
Díaz Rodríguez, Ángel |
|
2019 |
|
5 |
p. 203-209 |
artikel |
34 |
“Methodological notes”: a new and important section in Clínica e Investigación en Arteriosclerosis
|
Ribalta , Josep |
|
|
|
5 |
p. 243 |
artikel |
35 |
Nanotechnology, a new paradigm in atherosclerosis treatment
|
Martín Giménez, Virna M. |
|
2017 |
|
5 |
p. 224-230 7 p. |
artikel |
36 |
PCSK9 inhibitors: A new improvement for health
|
Perelló Camacho, Eva |
|
2019 |
|
5 |
p. 241-243 |
artikel |
37 |
Planetary health diet: do we have to reconsider the recommendations based on the Mediterranean diet?
|
Pérez-Martínez, Pablo |
|
2019 |
|
5 |
p. 218-221 |
artikel |
38 |
Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases
|
Ruiz-García, Antonio |
|
2018 |
|
5 |
p. 197-208 |
artikel |
39 |
Prevalence of severe hypercholesterolemia observed in different hospitals in Andalusia and Ceuta
|
Arrobas Velilla, Teresa |
|
|
|
5 |
p. 217-223 |
artikel |
40 |
Role of increased central arterial stiffness in macro and microvascular damage in patients with coronary artery disease
|
Hidalgo-Santiago, Juan Carlos |
|
|
|
5 |
p. 224-234 |
artikel |
41 |
Sedentarism, a disease from xxi century
|
Arocha Rodulfo, J. Ildefonzo |
|
2019 |
|
5 |
p. 233-240 |
artikel |
42 |
Severe hypertriglyceridemia. Clinical characteristics and therapeutic management
|
Masson, Walter |
|
2018 |
|
5 |
p. 217-223 |
artikel |
43 |
Statin treatment and increased diabetes risk. Possible mechanisms
|
Climent, Elisenda |
|
2019 |
|
5 |
p. 228-232 |
artikel |
44 |
The concept of severe hypertriglyceridaemia and its implications for clinical practice
|
Sala, Xavier Pintó |
|
2018 |
|
5 |
p. 193-196 |
artikel |
45 |
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias
|
Pedro-Botet, Juan |
|
|
|
5 |
p. 209-218 |
artikel |
46 |
Use of the cardiovascular polypill 40mg in secondary cardiovascular prevention
|
Marzal, Domingo |
|
2018 |
|
5 |
p. 240-247 |
artikel |